AAEON's GENE-APL7 Subcompact Board Deployed for Medical Research

April 23, 2020


AAEON's GENE-APL7 Subcompact Board Deployed for Medical Research

AAEON's GENE-APL7 3.5" Subcompact board is deployed in medical research to develop treatments and vaccines for the ongoing COVID-19 pandemic.

Due to the increasing cases of COVID-19, biotech developers are deploying blood and virus testing devices to help. Many of these machines are powered by the GENE-APL7 subcompact board, featuring Intel processors, from AAEON to provide accurate results for medical researchers.

The GENE-APL7 3.5"" subcompact board is small in size, making it ideal for fitting into medical equipment. The GENE-APL7 can be expanded to support up to 10 USB ports and 11 COM ports, allowing it to interface with multiple testing devices to provide sample analysis. 

The GENE-APL7 can be embedded into machines with fanless operation.  The GENE-APL7 supports multiple video outputs including eDP and VGA with support for 4K HD.

The GENE-APL7 is deployed to many applications within the medical field, including hospital telemedicine equipment, and in US pharmacies for applications including customer data management and real-time sharing of medical records. 

For more information, please visit www.aaeon.com

Featured Companies

AAEON Technology Inc.

5F, No. 135, Lane 235, Pao Chiao Rd.
Hsin-Tien Dist, New Taipei City 231

Tiera Oliver, editorial intern for Embedded Computing Design, is responsible for web content edits as well as newsletter updates. She also assists in news content as far as constructing and editing stories. Before interning for ECD, Tiera had recently graduated from Northern Arizona University where she received her B.A. in journalism and political science and worked as a news reporter for the university's student led newspaper, The Lumberjack.

More from Tiera